D03.122

Clinical Causes: Prolonged exposure to ultraviolet (UV) radiation from sunlight or tanning beds Having fair skin, light-colored eyes, or a history of excessive sun exposure Genetic predisposition to skin cancers History of previous skin cancers or precancerous skin lesions Presence of pigmented spots or moles that may undergo malignant transformation

Key Symptoms: A persistent pigmented or non-pigmented lesion on the eyelid that may be asymptomatic Changes in the size, shape, or color of an existing mole or pigmented patch A flat or slightly elevated lesion with irregular borders Lesions that develop crusting, ulceration, or bleeding Discoloration or pigmentation that extends beyond the lesion itself

Diagnosis Path: Healthcare providers typically evaluate suspected lesions through a thorough physical examination. Dermoscopy, a non-invasive imaging technique, can help in assessing pigmented skin lesions more clearly. Confirmatory diagnosis involves taking a skin biopsy—removing a small tissue sample from the lesion for microscopic examination. The biopsy results indicate whether the lesion is melanoma in situ and help determine appropriate management. Additional imaging or tests may be used if the diagnosis is uncertain or if there is concern about spread, though in situ melanoma is confined to the upper skin layers.

Treatment Protocols: Treatment options focus on complete removal of the melanoma in situ to prevent progression. Common approaches include: - Surgical excision with appropriate margins to ensure all abnormal cells are removed - Mohs micrographic surgery, which allows precise removal of cancerous tissue while sparing healthy tissue - Topical treatments such as imiquimod or 5-fluorouracil in selected cases, especially when surgical options are limited - Regular follow-up appointments for monitoring any recurrence or new lesions Early diagnosis and treatment are crucial to prevent melanoma from becoming invasive or spreading to other parts of the body.